Stored and frozen sera from patients with scleroderma and other connective tissue disorders including rheumatoid arthritis are reported to be occasionally cytotoxic to cultured human endothelial cells. -4 It has therefore been suggested that a factor in serum has a pathogenic role in the vascular and microvascular complications of these diseases. The observation that patients with giant cell arteritis also have a serum cytotoxic factor which falls with steroid therapy would support this view. 3 The nature of the serum factor has not been defined, nor is it established whether it is also present in fresh sera. Kahaleh and LeRoys have recently published evidence that endothelial cell cytotoxicity is mediated in vitro via a protease mechanism associated with a functional deficiency of protease inhibitors in scleroderma sera that develops in vivo. However, Cohen et al. 4 demonstrated that the factor, which was contained within the protein fraction and was heat-stable, did not have esteroproteolytic activity and suggested that it may be a lipoprotein. As low density lipoprotein (LDL) is known to be cytotoxic to human endothelial cells,6 7 this hypothesis is attractive.
Accepted for publication 25 July 1984. Correspondence to Dr D. R. Blake. LDL contains a large proportion of unsaturated lipid and is unique among the serum lipoproteins in its susceptibility to autoxidation with storage, to give peroxides.8 ' Human endothelial cell and fibroblast cytotoxicity can be inhibited by preparing LDL in the presence of antioxidants and promoted by increasing their content of lipid peroxides.292
The direct measurement of peroxidised LDL is difficult. However, it shares with the coppercontaining protein caeruloplasmin the ability to oxidise ferrous iron. This, however, is a stoichiometric rather than enzymatic reaction.'-15 Such activity can be measured directly within the serum and distinguished from that of caeruloplasmin by its resistance to the enzyme inhibitor azide.16
In this paper we report an association between azide resistant ferroxidase-like activity (ARFLA) and human endothelial cell cytotoxicity in stored sera. We also demonstrate that the progressive accumulation of ARFLA that occurs in stored sera is greater in patients with necrotising arteritis than in those with rheumatoid synovitis with or without extra-articular disease, or polymyalgia rheumatica/ giant cell arteritis. We suggest that the ARFLA measured in these sera is due to the presence of oxidised lipoprotein and speculate that differences between patient groups reflect the concentrations of circulating pro-oxidants in vivo. The observed functional defect in protease inhibitors5 may thus be explained by oxidative damage in vivo and by lipid peroxide damage in vitro.
Materials and methods

PATIENTS
The sera from 43 patients were examined for azide-inhibitable and azide-resistant ferroxidase activity (see below). Blood samples were collected into plastic containers to avoid contamination with iron from glass (promotes lipid peroxidation) and without exposure to anticoagulants. Sera, when aliquoted into plastic containers, were frozen at -20°C immediately and stored under identical storage conditions until use. All samples were stored for between 24-30 months. Patient sera were divided into three groups. Group A consisted of 12 patients with systemic necrotising arteritis (polyarteritis nodosa (six), Wegener's granulomatosis (three), and necrotising arteritis associated with rheumatoid synovitis (three)). Group B included 25 patients with definite rheumatoid arthritis (American Rheumatism Association criteria). These patients had either uncomplicated synovitis or rheumatoid disease with active extra-articular disease, but not necrotising arteritis. Group C consisted of six patients with large vessel/giant cell arteritis (Takayasu's arteritis (three), giant cell arteritis/ polymyalgia rheumatica (three)). were incubated for 2 hours at 37°C. Each contained 0-25 ml of serum and 075 ml of 0-1 M potassium buffer, pH 7-4, (containing 4 mM CaC12) and 25 ,ug/ml phospholipase C (type 1; Sigma), omitting phospholipase C in controls. The ARFLA of 25 ,ul of each mixture was determined.
CELL CULTURE
Human endothelial cells (EC) were cultured essentially by the method of Jaffe et al. 20 Briefly, human umbilical cords were washed with 0-1 M phosphate buffered saline (PBS), pH 7*2, and the umbilical vein was cannulated and washed through with PBS.
Collagenase (2 mg/ml in PBS, Sigma) was passed in and the cord incubated at 37°C for 15 minutes. Endothelial cells were collected by flushing through with PBS and pelleted. They were then resuspended in 5 ml medium 199 tissue culture medium (Flow, Irvin, UK), containing 10% fetal calf serum (Gibco, Uxbridge, UK,) or pooled human AB serum, penicillin, streptomycin, and 25 mM HEPES buffer per cord, and cultured in a 25 cm3 flask. The flask was incubated in an atmosphere of 5% C02/95% air at 37°C. The next day the cells were washed once with PBS, and fresh medium replaced. EC were confirmed by morphological appearance and factor VIII staining by indirect immunofluorescence (> 90% positive).
CYTOTOXICITY ASSAY Serum cytotoxicity measurements were performed by a modification of the method described by Hawker and Hawker.2' EC were harvested by digestion with 5 mg/l trypsin or dispase (Gibco) for five minutes, followed by collection and pelleting. Excess tryptic activity was suppressed by addition of 2 ml of fetal calf serum. The pellet was resuspended in 1 ml minimum essential medium (MEM) (Flow), 50-100 gl of '"indium (50-100 itCi) (Amersham, UK) added and incubated for two minutes. This was followed by two washes of 10 ml MEM. Cells were resuspended at 1 x 106/ml in MEM and 100 ,ul dispensed to each well of a Nunc 96 well microtitre plate (Gibco). A further 100 jil of serum (test) or medium (control) was added, and the plate incubated for three hours at 37°C. After incubation 100
IlI Triton X-100 (BDH, Poole, UK) was added to selected wells to establish maximal release, and the plate was centrifuged for five minutes at 100 g. A 100 ,Il aliquot was taken for counting on a singlewell type gamma counter for 10 seconds. The cytotoxicity index (CI) was calculated according to the following method:
The cytotoxicity index was defined from the mean of 2-3 separate estimations, dependent on the amount of available serum.
Results
Immunoelectrophoresis of sera containing significant amounts of azide-resistant ferroxidase-like activity (ARFLA) against monospecific antihuman LDL antiserum gave a precipitin band which stained strongly with Perl's reagent after pretreatment with a ferrous salt solution. These sera also showed no loss of activity on incubation with phospholipase C, indicating a non-enzymic ferrous iron oxidising activity of LDL.19 In fresh sera, from both the clinical groups and normal controls, ARFLA accounted for 0 to 10% of the total ferroxidase activity in the serum. There were no significant differences in this activity between the groups. In terms of caeruloplasmin 'equivalents' (see 'Patients and methods') six normal fresh sera contained 10±3 (ISD) mg/l. In normal sera (six samples stored at -20°C for 2-4 years) the mean ARFLA had increased to 280±68 mg/l, or roughly 30 times; 6-9 months' storage produced no significant change, though the mean level of ARFLA in this group was raised (Fig. 1) . The CI of normal sera also increased with time of storage at -20°C: 2-4 years' storage of normal sera resulted in a mean increase in cytotoxicity which was 21½2 times that of fresh normal sera. However, even after this period of storage it was still significantly lower (p<O-OOl) than in the group A sera stored for the shorter period (24-30 months) .
ARFLA was found in most of the clinical samples that had been stored at -20°C for similar periods of time (see 'Patients and methods'), and values are To 'mimic' the effect of prolonged storage fresh serum from one normal control was incubated at 37°C along with fresh sera from one patient with a necrotising arteritis and one with rheumatoid synovitis. ARFLA was measured after four days' incubation. The normal control value increased by > 100% (12.6 mg/1-30-0 mg/l). The rheumatoid sample showed no significant difference from control (14-4- nin giving an allylic hydrogen which is susceptible to abstrac4ps A to C tion from the molecule by radical species, such as FLA measured the hydroxyl radical. This reaction also generates a for radical product, setting up a chain reaction in the or triplicate presence of 02-Under conditions of insufficient 02 !sfor each tension molecular 02 will not react with the first radical product and a preperoxide will be formed by a radical termination reaction.25 Such preperoxides are considerably more likely to peroxidise in vitro ), which in-than the original polyunsaturated fatty acid, and in l. No patient the presence of 02 in vitro will generate a in any form. hydroperoxide. 25 Frieden et al. 13 14 have suggested cytotoxicity that lipoprotein hydroperoxides are generated on f the clinical storage and have ferroxidase-like activity. We have trol samples demonstrated that such ferroxidase-like activity is ;hion to test associated with serum-induced cell cytotoxicity. The ion between rate of formation of ARFLA on storage is characterfound and is istic of an autoxidative reaction. However, although rman's rank ARFLA levels were correlated with a corresponding gh the rela-increase in cytotoxicity, there was a contrastingly as the log 10 disproportionate increase of cytotoxicity with time correlation of storage. This may relate to the insensitivity of the cytotoxicity assay, though it is reasonable to conclude that free radicals and lipid peroxides are responsible for endothelial cell damage indirectly.
It has recently been suggested that endothelial cell cytotoxicity is mediated via a proteolytic mechanism involving a depression of antiprotease activities in scleroderma sera.5 Such a concept is compatible with our data, as in scleroderma the defect in the antiprotease system is not a depression of antigenic levels of a2-macroglobulin and a1-antitrypsin, but a functional deficiency of trypsin inhibitory capacity. One of the mechanisms for functional defects in serum protease inhibitors is by direct damage from reactive oxygen species generated by phagocytosing neutrophils. 6 Our data suggest that patients with necrotising arteritis develop this vasculitic complication in a fashion that is distinct from patients with large vessel/giant cell arteritis. A neutrophil-mediated free radical reaction would appear to be a likely basis for the underlying pathology, uniting the mechanistic concepts that have been reported to date5 29 30 (Fig. 4) . This concept is further supported 
